NCT06587217 - Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

April 3, 2025

Study Completion Date

April 3, 2025

Conditions

Parkinsonian Signs in Older Persons

Interventions

DRUG

Carbidopa 25 mg

Participants will take one 25mg Carbidopa tablet 3 times a day for 10 days.

DRUG

Carbidopa-Levodopa 25/100 mg

Participants will take one 25/100mg carbidopa-levodopa tablet 3 times a day on days 4-6, then increase to 1.5 tablets 3 times a day on days 7-10.

Trial Locations (2)

Domino's Farms, Ann Arbor

University Hospital, Ann Arbor

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

University of Michigan

OTHER